Proton pump inhibitor提供了新颖的噻二唑化合物,该化合物是有效的质子泵抑制剂,通过抑制质子泵酶H Provides novel thiadiazole compounds that are effective proton pump inhibitor, by inhibiting the proton pump enzyme HK·卡里米安T·F·塔姆D·德西莱茨S·李T·坎佩莱托...
请检查并且再采取电话号码...” [translate] ahumour 幽默 [translate] aProton Pump Inhibitor drugs (PPIs): Drug Safety Communication – Low Magnesium Levels Can Be Associated With Long-Term Use 氢核泵浦抗化剂使 (PPIs服麻醉剂): 药物安全通信-低镁水平可以同长期用途联系在一起 [translate] 英语翻译...
proton pump inhibitor 英 [ˈprəʊˌtɔn pʌmp inˈhibitə]美 [ˈproˌtɑn pʌmp ɪnˈhɪbɪtɚ][释义][医] 质子泵抑制剂;[例句]The present preparation comprises a fixed oral dosage form ...
Bamaquimast是proton pump的抑制剂,来自专利专利US2005165041化合物实例138。注:本品仅可用于科研实验,严禁用于临床医疗及其他用途!CAS号:135779-82-7纯度:98.79%分子式:C16H21N3O3分子量:303.36结构式:储存条件:-20℃,有效期2年,溶入溶剂后-20℃请尽量在一个月内使用。相关搜索:proton pump抑制剂(Bamaquimast)...
Omeprazole is a proton pump inhibitor which inhibits secretion of gastric acid by irreversibly blocking the enzyme system of hydrogen/potassium adenosine triphosphatase (H+/K+-ATPase), the “proton pump” of the gastric parietal cell. The drug is used in conditions where the inhibition of gastric...
Description Omeprazole is a proton pump inhibitor that blocks H(+)-K(+)-ATPase, used to treat dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger–Ellison syndrome. Targets Proton pump [1] H(+)-K(+)-ATPase [1] In vitro In vitro Omeprazol...
求翻译:Proton Pump Inhibitor是什么意思?待解决 悬赏分:1 - 离问题结束还有 Proton Pump Inhibitor问题补充:匿名 2013-05-23 12:21:38 质子泵抑制剂 匿名 2013-05-23 12:23:18 质子泵抑制剂 匿名 2013-05-23 12:24:58 氢核泵浦抗化剂 匿名 2013-05-23 12:26:38 质子泵抑制剂 匿名 ...
Omeprazole, 98%, a proton pump inhibitor品牌: J&K 产品编号: 178077 CAS: 73590-58-6 分子式: C17H19N3O3S 分子量: 345.42 纯度: 98% 包装库存价格 暂无数据 我的购物车 推荐产品 6-甲氧基-2-(((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)亚磺酰基)-1H-苯并[d]咪唑(埃索美拉唑杂质),98% 2-...
Gouraud A, Vochelle V, Descotes J, Vial T. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clin Drug Investig. 2010;30(8):559–63.Gouraud, A, Vochelle, V, Descotes, J (2010) Proton pump inhibitors induced neutropenia: possible cross-...
The present invention is concerned with an oral pharmaceutical formulation containing a proton pump inhibitor (PPI) which is suitable for the treatment of gastric acid related diseases in man and animals. More specifically, the composition is a paste, and is particularly suitable for delivery of a...